Watch Ticker

Voyager Therapeutics, Inc. Common Stock

Go to Voyager Therapeutics, Inc. Common Stock Website

$3.21

0.00 (0.00%)

Live

Previous Close

$3.21

Day Range

$0 - $0

Previous Day Range

$2.8838 - $3.34

Market Cap

$163.8 million USD

Day Vol.

Previous Day Vol.

1.5 million

Currency

USD

Primary Exchange

Nasdaq

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy appr...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Voyager Therapeutics - Voyager Adds Fourth Wholly-Owned Alzheimer’s Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach

Voyager Therapeutics expanded its Alzheimer's disease franchise by introducing a new gene therapy program targeting APOE, complementing existing tau and amyloid assets. The program aims to reduce APOE4 variant expression while delivering the protective APOE2 variant using an innovative IV-delivered TRACER capsid.

Related tickers: VYGR, AZN, NVS, NBIX.

Read Full Article

N/A - Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication

Voyager Therapeutics published data in Molecular Therapy demonstrating the ability of a novel AAV capsid, VCAP-102, to cross the blood-brain barrier and transduce various brain regions in rodents and non-human primates. The company also highlighted its next-generation CNS capsids and non-viral delivery approaches.

Related tickers: VYGR.

Read Full Article

Trending Tickers

Please sign in to view